Can you provide the last earnings date for BELLICUM PHARMACEUTICALS INC?
BELLICUM PHARMACEUTICALS INC (BLCM) last reported earnings on 5/11/2023.
BELLICUM PHARMACEUTICALS INC (BLCM) Earnings History & Surprises
NASDAQ:BLCM • US0794814048
Current stock price
0.622 USD
-0.07 (-9.72%)
At close:
0.6288 USD
+0.01 (+1.09%)
After Hours:
BLCM Earnings overview
Past quarterly earnings results for BELLICUM PHARMACEUTICALS INC (BLCM), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Aug 9, 2023
- Period
- Q2 / 2023
- EPS Estimate
- -$0.30
- Revenue Estimate
Last Reported
Most Recent- Release Date
- May 11, 2023
- Period
- Q1 / 2023
- EPS Reported
- -$0.26
- EPS Surprise
- 25.03%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2023 | -0.26 | -0.35 | 25.03% | -4.00% | 8K | - | - | |
| Q4 2022 | -0.20 | -0.95 | 78.81% | -282.72% | 500K | - | - | |
| Q3 2022 | -0.23 | -0.65 | 64.77% | -428.57% | 1M | - | -80.00% | |
| Q2 2022 | -0.13 | -0.70 | 81.53% | 40.91% | - | -100.00% | ||
| Q1 2022 | -0.25 | -0.68 | 63.42% | 76.85% | - | - | ||
| Q4 2021 | 0.11 | -0.41 | 126.96% | -88.78% | 500K | - | - | |
| Q3 2021 | 0.07 | -1.40 | 105.01% | 138.89% | 5M | 253.749K | 1,870.45% | - |
| Q2 2021 | -0.22 | -1.40 | 84.26% | 97.63% | 700K | 253.749K | 175.86% | - |
| Q1 2021 | -1.08 | -1.40 | 22.71% | -199.08% | 253.749K | -100.00% | - | |
| Q4 2020 | 0.98 | -1.08 | 190.64% | - | 500K | 253.749K | 97.05% | - |
| Q3 2020 | -0.18 | -3.21 | 94.39% | - | 255K | -100.00% | - | |
| Q2 2020 | -9.29 | -3.40 | -173.51% | - | 919.53K | -100.00% | - | |
| Q1 2020 | 1.09 | -2.78 | 139.14% | - | 409.02K | -100.00% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
62.53%
Max EPS beat (4)
81.53%
Min EPS beat (4)
25.03%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, BLCM has consistently beaten EPS estimates in all releases
In the last 4 quarters, BLCM has beaten the EPS estimates by 62.5% on average.
Related analysis
BELLICUM PHARMACEUTICALS INC / BLCM Earnings FAQ
Did BLCM stock beat earnings estimates in the most recent quarter?
BELLICUM PHARMACEUTICALS INC (BLCM) beat EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does BLCM stock beat earnings estimates?
In the last 4 quarters, BELLICUM PHARMACEUTICALS INC (BLCM) has beaten EPS estimates in 4 out of 4 releases.